Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift.

By J. Choukroun, A. Diss, Alain Simonpieri, M. Girard, C. Schoeffler, Steve L Dohan, A. Dohan, J. Mouhyi, D. Dohan. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2006

776 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Oral Surgery, Urology

View Paper: https://www.semanticscholar.org/paper/cc6c80b80ee7613871aeb1dd8f65ef76d49acd43

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Urology

1. P. Doglioli
2. D. M. Dohan Ehrenfest
3. G. Sammartino
4. G. M. de Peppo

Citations in the corpus

• Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies (2009, background): “When delicately pressed between two gauzes, the PRF clot becomes a strong membrane with high potential, both in clinical application (Choukroun et al. 2006a, 2006b; Braccini and Dohan 2007; Saadoun and Touati 2007; Diss et al. 2008) and tissue engineering (Choukroun et al. 2007; Figure 1).”